“Experience of Using Stereotactic Ablative Radiotherapy for Radical Treatment of Low and Intermediate Risk Prostate Cancer”, Вопр. онкол., vol. 70, no. 2, pp. 292–298, May 2024, doi: 10.37469/0507-3758-2024-70-2-292-298.